Barely Significant
← all excerpts

Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating.

J Nanobiotechnology · 2024 · PMC11282782 · PMID 39061092

1
hedged sentence
closest p
boldest claim

The sentences

an increasing trendno p-value reported
Besides, on the condition that C6 concentrations increase from 25 to 200 ng/mL, the intracellular fluorescence intensity also indicates an increasing trend, demonstrating the cellular uptakes of NCM460 cells and Raw264.7 cells were dose-dependent (Fig. 3 C, G).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.